Exicure, Inc. Announces Appointment of New CEO and CFO and Changes to Board of Directors
Exicure, Inc. , historically an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets, today announced that, effective as...
Source: marketscreener.com